Watchlist Price Alert

OS Therapies (OSTX)

NYSE: OSTX · Real-Time Price · USD

1.94

-0.03 (-1.52%)

At close: May 09, 2025, 3:59 PM

1.88

-3.02%

After-hours: May 09, 2025, 07:59 PM EDT

OS Therapies Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q1 2022	Q4 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Mar 31, 2022	Dec 31, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.21	18.48
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1.21	-18.48
Operating Income	-2.97M	-2.44M	-779.8K	-630.23K	-1.16M	-622.21K	-1.52K	-1.05K	-1.74K	-889.39	-1.27K
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-2.99M	-2.88M	-1.56M	-1.46M	-1.46M	-1.97M	-2.51K	-1.85K	-2.55K	-1.36K	-2.36K
Net Income	-2.99M	-2.88M	-1.56M	-1.46M	-1.46M	-1.97M	-2.51K	-1.85K	-2.55K	-1.36K	-2.36K
Selling & General & Admin	2.1M	1.23M	383.23K	268.42K	132.88K	167.7K	522.48	294.25	642.62	203.42	555.27
Research & Development	870.47K	1.21M	396.57K	361.81K	1.02M	454.5K	992.90	753.78	1.1K	684.76	692.97
Other Expenses	n/a	n/a	n/a	n/a	5.15K	n/a	0.00	n/a	-0.00	n/a	-0.00
Operating Expenses	2.97M	2.44M	779.8K	630.23K	1.16M	622.21K	1.52K	1.05K	1.74K	888.18	1.25K
Interest Expense	7.56K	437.84K	777.68K	828.76K	307.53K	1.35M	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	2.97M	2.44M	779.8K	630.23K	1.16M	622.21K	1.52K	1.05K	1.74K	889.39	1.27K
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	123.77M	15.9M	20.6M	20.05M	n/a	20.05M	5.27M	10.04M	9.86M	9.76M	13.41M
Shares Outstanding (Diluted)	123.77M	15.9M	20.6M	20.05M	n/a	23.1M	5.34M	10.21M	9.98M	9.98M	13.41M
EPS (Basic)	n/a	-0.18	-0.08	-0.07	n/a	-0.1	-0.00	-0.00	-0.00	-0.00	-0.00
EPS (Diluted)	n/a	-0.18	-0.08	-0.07	n/a	-0.09	-0.00	-0.00	-0.00	-0.00	-0.00
EBITDA	-2.98M	-2.44M	-779.1K	-629.54K	-1.16M	-618.89K	-1.51K	-1.05K	-1.74K	-889.19	-1.27K
EBIT	-2.98M	-2.44M	-779.8K	-630.23K	-1.16M	-622.21K	-1.52K	-1.05K	-1.74K	-889.39	-1.27K
Depreciation & Amortization	1.39K	n/a	695.00	695.00	n/a	3.31K	0.81	0.10	0.20	0.20	0.20